DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)
Лекарствени продукти, съдържащи DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)
| Търговско име | Концентрация | Производител |
|---|---|---|
| Qdenga | --¹ After reconstitution, 1 dose (0.5 mL) contains: Dengue virus serotype 1 (live, attenuated)*: ≥ 3.3 log10 PFU**/dose Dengue virus serotype 2 (live, attenuated)#: ≥ 2.7 log10 PFU**/dose Dengue virus serotype 3 (live, attenuated)*: ≥ 4.0 log10 PFU**/dose Dengue virus serotype 4 (live, attenuated)*: ≥ 4.5 log10 PFU**/dose *Produced in Vero cells by recombinant DNA technology. Genes of serotype-specific surface proteins engineered into dengue type 2 backbone #Produced in Vero cells by recombinant DNA technology **PFU = Plaque-forming units | Takeda Pharmaceuticals International AG Ireland Branch |